Filing Details
- Accession Number:
- 0001209191-21-050648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 17:19:30
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-10 17:19:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779787 | Richard Chen | C/O Personalis, Inc. 1330 O'Brien Drive Menlo Park CA 94025 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-06 | 15,564 | $0.00 | 102,413 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-06 | 15,564 | $21.18 | 86,849 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-06 | 4,436 | $21.22 | 82,413 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-08-06 | 9,618 | $0.00 | 9,618 | $1.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-08-06 | 5,946 | $0.00 | 5,946 | $0.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 44,728 | 2023-11-13 | No | 4 | M | Direct | |
| 0 | 2022-03-07 | No | 4 | M | Direct |
Footnotes
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person.
- The weighted average sale price for the transaction reported was $21.18, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $21.22, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The Shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
